{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T17:17:19Z","timestamp":1716830239777},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,9,30]],"date-time":"2010-09-30T00:00:00Z","timestamp":1285804800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s00520-010-1015-6","type":"journal-article","created":{"date-parts":[[2010,9,29]],"date-time":"2010-09-29T15:03:34Z","timestamp":1285772614000},"page":"435-438","source":"Crossref","is-referenced-by-count":7,"title":["The use of fentanyl buccal tablets as breakthrough medication in patients receiving chronic methadone therapy: an open label preliminary study"],"prefix":"10.1007","volume":"19","author":[{"given":"Sebastiano","family":"Mercadante","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Ferrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Arcuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,30]]},"reference":[{"key":"1015_CR1","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/(SICI)1097-0142(19960815)78:4<852::AID-CNCR23>3.0.CO;2-T","volume":"78","author":"E Bruera","year":"1996","unstructured":"Bruera E, Pereira J, Watanabe S et al (1996) Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine. Cancer 78:852\u2013857","journal-title":"Cancer"},{"key":"1015_CR2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1200\/JCO.2004.03.172","volume":"22","author":"E Bruera","year":"2004","unstructured":"Bruera E, Palmer JL, Bosnjak S et al (2004) Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study. J Clin Oncol 22:185\u2013192","journal-title":"J Clin Oncol"},{"issue":"4 suppl 1","key":"1015_CR3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jpain.2006.01.132","volume":"7","author":"M Darwish","year":"2006","unstructured":"Darwish M, Robertson P, Tracewell W et al (2006) Comparative availability of the novel fentanyl effervescent buccal tablet formulation: an open label crossover study. J Pain 7(4 suppl 1):35","journal-title":"J Pain"},{"key":"1015_CR4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ejpain.2008.06.014","volume":"13","author":"AN Davies","year":"2009","unstructured":"Davies AN, Dickman A, Reid C, Stevens AM, Zeppetella G (2009) The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. Eur J Pain 13:331\u2013338","journal-title":"Eur J Pain"},{"key":"1015_CR5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/J354v18n04_05","volume":"18","author":"KR Eugenio","year":"2004","unstructured":"Eugenio KR (2004) Profound morphine tolerance following high-dose methadone therapy. J Pain Palliat Care Pharm 18:47\u201354","journal-title":"J Pain Palliat Care Pharm"},{"key":"1015_CR6","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jpainsymman.2004.03.003","volume":"28","author":"K Fisher","year":"2004","unstructured":"Fisher K, Stiles C, Hagen NA (2004) Characterization of the early pharmacologic profile of oral methadone for cancer-related breakthrough pain: a pilot study. J Pain Symptom Manage 28:619\u2013625","journal-title":"J Pain Symptom Manage"},{"key":"1015_CR7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1089\/jpm.2006.0163","volume":"10","author":"NA Hagen","year":"2007","unstructured":"Hagen NA, Fisher K, Stiles C (2007) Sublingual methadone for the management of cancer-related breakthrough pain: a pilot study. J Palliat Med 10:331\u2013337","journal-title":"J Palliat Med"},{"key":"1015_CR8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/jpm.2006.0151","volume":"10","author":"NA Hagen","year":"2007","unstructured":"Hagen NA, Fisher K, Victorino C, Farrar JT (2007) A titration strategy is needed to manage breakthrough cancer pain effectively: observations from data pooled from three clinical trials. J Palliat Med 10:47\u201355","journal-title":"J Palliat Med"},{"key":"1015_CR9","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1054\/bjoc.2001.1680","volume":"84","author":"GW Hanks","year":"2001","unstructured":"Hanks GW, De Conno F, Cherny N et al (2001) Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 84:587\u2013593","journal-title":"Br J Cancer"},{"key":"1015_CR10","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1167::AID-CNCR23>3.0.CO;2-3","volume":"82","author":"P Lawlor","year":"1998","unstructured":"Lawlor P, Turner K, Hanson J, Bruera E (1998) Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study. Cancer 82:1167\u20131173","journal-title":"Cancer"},{"key":"1015_CR11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0885-3924(00)00236-0","volume":"21","author":"S Mercadante","year":"2001","unstructured":"Mercadante S, Portenoy RK (2001) Opioid poorly responsive cancer pain. Part 2. Basic mechanisms that could shift dose\u2013response for analgesia. J Pain Symptom Manage 21:255\u2013264","journal-title":"J Pain Symptom Manage"},{"key":"1015_CR12","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ctrv.2006.03.001","volume":"32","author":"S Mercadante","year":"2006","unstructured":"Mercadante S, Bruera E (2006) Opioid switching: a systematic and critical review. Cancer Treat Rev 32:304\u2013315","journal-title":"Cancer Treat Rev"},{"key":"1015_CR13","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.ejpain.2008.01.013","volume":"12","author":"S Mercadante","year":"2008","unstructured":"Mercadante S, Porzio G, Ferrera P et al (2008) Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. Eur J Pain 12:1040\u20131046","journal-title":"Eur J Pain"},{"key":"1015_CR14","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jpainsymman.2003.09.006","volume":"27","author":"S Mercadante","year":"2004","unstructured":"Mercadante S, Villari P, Ferrera P, Bianchi M, Casuccio A (2004) Safety and effectiveness of intravenous morphine for episodic-breakthrough pain, using a fixed ratio with the oral daily morphine dose. J Pain Symptom Manage 27:352\u2013359","journal-title":"J Pain Symptom Manage"},{"key":"1015_CR15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jpainsymman.2007.04.018","volume":"35","author":"S Mercadante","year":"2008","unstructured":"Mercadante S, Intravaia G, Villari P, Ferrera P, Riina S, Mangione S (2008) Intravenous morphine for breakthrough (episodic-) pain in an acute palliative care unit: a confirmatory study. J Pain Symptom Manage 35:307\u2013313","journal-title":"J Pain Symptom Manage"},{"key":"1015_CR16","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1038\/sj.bjc.6603811","volume":"96","author":"S Mercadante","year":"2007","unstructured":"Mercadante S, Villari P, Ferrera P, Casuccio A, Mangione S, Intravaia G (2007) Transmucosal fentanyl vs intravenous morphine in doses proportional to basal opioid regimen for episodic-breakthrough pain. Br J Cancer 96:1828\u20131833","journal-title":"Br J Cancer"},{"key":"1015_CR17","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jpainsymman.2007.12.024","volume":"37","author":"S Mercadante","year":"2009","unstructured":"Mercadante S, Ferrera P, Villari P, Casuccio A, Intravaia G, Mangione S (2009) Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit. J Pain Symptom Manage 37:632\u2013641","journal-title":"J Pain Symptom Manage"},{"key":"1015_CR18","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/AJP.0b013e3181c4458a","volume":"26","author":"S Mercadante","year":"2010","unstructured":"Mercadante S, Villari P, Ferrera P, Mangione S, Casuccio A (2010) The use of opioids for breakthrough pain in an acute palliative care unit by using doses proportional to opioid basal regimen. Clin J Pain 26:306\u2013309","journal-title":"Clin J Pain"},{"key":"1015_CR19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0304-3959(01)00465-1","volume":"96","author":"N Moryl","year":"2002","unstructured":"Moryl N, Santiago-Palma J, Kornick C et al (2002) Pitfalls of opioid rotation: substituting another opioid for methadone in patients with cancer pain. Pain 96:325\u2013328","journal-title":"Pain"},{"key":"1015_CR20","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/01.ajp.0000210932.27945.4a","volume":"22","author":"RK Portenoy","year":"2006","unstructured":"Portenoy RK, Taylor D, Messina J, Tremmel L (2006) A randomized, placebo-controlled study of fentanyl buccal tablets for breakthrough pain in opioid-treated patients with cancer. Clin J Pain 22:805\u2013811","journal-title":"Clin J Pain"},{"key":"1015_CR21","first-page":"327","volume":"5","author":"N Slatkin","year":"2007","unstructured":"Slatkin N, Messina J, Segal T (2007) Fentanyl buccal tablets for relief of breakthrough pain in opioid-tolerant patients with cancer-related chronic pain. J Support Oncol 5:327\u2013334","journal-title":"J Support Oncol"},{"key":"1015_CR22","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1089\/jpm.2007.0285","volume":"11","author":"P Walter","year":"2008","unstructured":"Walter P, Palla S, Pei B et al (2008) Switching from methadone to different opioid: what is the equianalgesic ratio? J Palliat Med 11:1103\u20131108","journal-title":"J Palliat Med"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-010-1015-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-010-1015-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-010-1015-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:02:02Z","timestamp":1559080922000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-010-1015-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,30]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["1015"],"URL":"https:\/\/doi.org\/10.1007\/s00520-010-1015-6","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,30]]}}}